EuroAgeism
Published April 24, 2019 | Version v1
Journal article Open

Applicability of EU(7)-PIM criteria in cross-national studies in European countries. Therapeutic Advances in Drugs Safety. 2019. https://doi.org/10.1177/2042098619854014

Authors/Creators

  • 1. Charles University, Faculty of Pharmacy, Department of Clinical and Social Pharmacy; Charles University, 1st Faculty of Medicine, Department of Geriatrics and Gerontology
  • 2. Faculty of Pharmacy, Charles University, Department of Clinical and Social Pharmacy
  • 3. Universidade da Coruna, Department of Psychology, Area of Psychobiology, DICOMOSA Group
  • 4. The Czech Academy of Sciences, Institute of Computer Science, Department of Statistical Modelling
  • 5. Charles University, Faculty of Pharmacy, Department of Clinical and Social Pharmacy
  • 6. Yeditepe University, Department of Medical Biology, School of Medicine
  • 7. University of Szeged, Faculty of Pharmacy, Department of Clinical Pharmacy
  • 8. University of Belgrade, Faculty of Pharmacy, Department of Social Pharmacy and Pharmaceutical Legislation
  • 9. Universidade da Coruna, De, partment of Psychology, Area of Psychobiology, DICOMOSA Group
  • 10. Portuguese National Institute of Health, Department of Environmental Health; University of Porto, Institute of Public Health, EPIUnit

Description

The EU project EUROAGEISM H2020 (2017–2021), ESR7 project, focuses on prescribing of high-risk medications in older adults (so called PIMs, potentially inappropriate medications) and regulatory measures related to these medications, particularly in  European countries.

The EU7-PIM (potentially inappropriate medication) criteria presents the most comprehensive and up-to-date list of high-risk medications in older adults utilized in research in Europe. However, several country-specific studies documented differences in approval rates of high-risk medications for geriatric patients and different regulatory measures across EU countries.

This scientific article describes the differences between 6 European countries (Czech Republic, Spain, Portugal, Turkey, Hungary and Republic of Serbia) in approval rates and marketing of high-risk medications in older adults using the EU(7)-PIM criteria in comparison to the most known and most utilized American Geriatric Society (AGS) Beers 2015 PIM criteria.

Notes

article in the foreign journal with the IF

Files

Fialová D, Brkič J_article TADS 2019_EUROAGEISM H2020.pdf

Files (1.1 MB)

Additional details

Funding

European Commission
EuroAgeism - An international, multi-disciplinary, multi-sectoral training network on ageism 764632